A parainfluenza virus 5 (PIV5)-vectored intranasal vaccine for Lyme disease provides long-lasting protection against tick transmitted Borrelia burgdorferi in mice

por Gingerich, Maria Cristina, Nair, Nisha, Azevedo, J. Filipe, Samanta, Kamalika, Kundu, Suman, He, Biao, Gomes-Solecki, Maria
Publicado 2023

Intranasal parainfluenza virus type 5 (PIV5)–vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study

por Spearman, Paul, Jin, Hong, Knopp, Kristeene, Xiao, Peng, Gingerich, Maria Cristina, Kidd, Jamie, Singh, Karnail, Tellier, Marinka, Radziewicz, Henry, Wu, Samuel, McGregor, Matthew, Freda, Barbara, Wang, Zhaoti, John, Susan P., Villinger, Francois J., He, Biao
Publicado 2023